Michael D. McLean has worked with Dr. J. Christopher Hall for more than 10 years at the University of Guelph and has played a major role in the development of a system for the production of therapeutic antibodies and proteins in plants. This system has been adapted as a platform technology for antibody production by PlantForm Corporation. McLean has also worked on research topics such as antibody selection and development, antibody purification, antibody function and therapeutics, and bioremediation of environmental contaminants using plants engineered to express antibodies. Together, Hall and McLean have published over 20 papers, 3 patents, and raised over $5M for their academic research programs. Before working with Hall, McLean taught genetic engineering in the Molecular Biology department at Guelph and performed research on crop protection. Prior to that, he was a research fellow at the Children’s Hospital of Eastern Ontario in Ottawa on a team that identified a gene associated with human spinal muscular atrophy (SMA). McLean earned his Ph.D. at the University of Georgia in the area of plant genomics and has worked in biotechnology for more than 20 years. Michael D. McLean has worked with Dr. J. Christopher Hall for more than 10 years at the University of Guelph and has played a major role in the development of a system for the production of therapeutic antibodies and proteins in plants. This system has been adapted as a platform technology for antibody production by PlantForm Corporation. McLean has also worked on research topics such as antibody selection and development, antibody purification, antibody function and therapeutics, and bioremediation of environmental contaminants using plants engineered to express antibodies. Together, Hall and McLean have published over 20 papers, 3 patents, and raised over $5M for their academic research programs. Before working with Hall, McLean taught genetic engineering in the Molecular Biology department at Guelph and performed research on crop protection. Prior to that, he was a research fellow at the Children’s Hospital of Eastern Ontario in Ottawa on a team that identified a gene associated with human spinal muscular atrophy (SMA). McLean earned his Ph.D. at the University of Georgia in the area of plant genomics and has worked in biotechnology for more than 20 years.

Smart Drug Delivery Technology Nano medicine and Drug Delivery Drug targeting Drug Design and Drug Formulation Anti-Cancer Drug Discovery